Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06852170 · ClinicalTrials.gov registry record · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
A NA study of Substance-Related Disorders and Substance Abuse, sponsored by Chestnut Health Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 341
- Enrollment target
- 1
- Study location
NCT06852170: Recruiting NA study of Substance-Related Disorders and Substance Abuse, sponsored by Chestnut Health Systems.
NCT06852170 is a NA study of Substance-Related Disorders and Substance Abuse that is actively recruiting participants, run by Chestnut Health Systems. The registered enrollment target is 341 participants, below the 1,515-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06852170, a NA study of Substance-Related Disorders and Substance Abuse, is actively recruiting participants, sponsored by Chestnut Health Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 341 participants
- Enrollment target
- 1
- Study location
Study Summary
Oregon's decision makers (e.g., community service providers, public health, justice, advocacy groups, payers) are calling for comprehensive, current, and trusted data to inform how they allocate resources to improve substance use services and mitigate the growing opioid and methamphetamine epidemics in their state. Consistent with the HEAL Data2Action call for Innovation projects that drive action with data in real-world settings, this study will refine and test the impact of a novel implementation strategy to engage cross- sector decision makers and make data that they identify as relevant to their decisions available to them in easy- to-use products. The proposed study aims to not only address critical knowledge gaps regarding how and when data can inform impactful, transparent decision-making, but to provide decision makers with the data that they need to achieve community-wide substance use prevention and treatment goals, including the increased delivery of high-quality, evidence-informed, services and the prevention of overdoses.
Primary Outcome
A measure of community engagement (Oetzel et al, 2018) which includes 2 subscales; collaboration, which includes 4 items answered on a Likert Scale ranging from Strongly Disagree to Strongly Agree, and synergy, which includes 7 items answered on a Likert Scale ranging from Not at All to To a Great Extent.
Conditions Studied
Interventions
- OTHER Co-Design Sessions (CDS)
- OTHER Data products
Study Locations (1)
Oregon
- Chestnut Health Systems - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2025-02-06 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What NCT06852170 shows while recruiting
NCT06852170 is an interventional study that assigns participants to a tested intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap, below the 1,515-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (77% lower).
The record links to 7 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Co-Design Sessions (CDS) is the first listed.
NCT06852170 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06852170 about?
NCT06852170 is a clinical study titled "Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention". Oregon's decision makers (e.g., community service providers, public health, justice, advocacy groups, payers) are calling for comprehensive, current, and trusted data to inform how they allocate resources to improve substance use services and mitigate the growing opioid and methamphetamine epidemics...
What is the current status of trial NCT06852170?
This trial is currently recruiting. It is a NA study. The enrollment target is 341 participants. The study started on 2025-02-06. Estimated completion is 2028-08-31.
What conditions does trial NCT06852170 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Substance Abuse, Implementation Science, Decision Making, Decision Making, Shared.
What interventions are being tested in trial NCT06852170?
The interventions under investigation include: Co-Design Sessions (CDS) (OTHER), Data products (OTHER).
Who is sponsoring clinical trial NCT06852170?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06852170 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06852170's enrollment target sits among peer trials
341 14th of 58 higher than 45 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
- NCT06544941 · 342 participants · NA
Improving Maternal Sleep and Mental Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI